You are here

Prezista

J&J to seek appeal of $150M verdict in long-spanning HIV meds off-label marketing case

Fierce Pharma

Mon, 06/17/24 - 10:31 pm

whistleblower lawsuits

J&J HIV drug already in Covid-19 clinical trials flunks in vitro study

MedCity News

Wed, 04/8/20 - 11:42 pm

clinical trials

J&J warns doctors not to count on Prezista as a COVID-19 treatment

Fierce Pharma

Tue, 03/17/20 - 12:06 pm

Janssen gets EU nod for continuous manufacturing

BioPharma Dive

Fri, 06/30/17 - 09:45 am

drug manufacturing

Merck’s HIV drug doravirine looks solid — though far less stellar than rivals — in 1st PhIII

Endpoints

Wed, 02/15/17 - 09:45 am

J&J says won't enforce AIDS drug patent in Africa

Reuters

Thu, 11/29/12 - 11:04 am

Johnson & Johnson says FDA did not approve once-per-day version of HIV pill Prezista

Yahoo/AP

Tue, 05/29/12 - 04:48 pm

Gilead and J&J expand HIV cocktail partnership

Yahoo/AP

Wed, 11/16/11 - 09:51 am

Gilead, Tibotec to work on new HIV-fighting drug combos

Bizjournals.com

Tue, 06/28/11 - 11:29 pm

Gilead Sciences

What’s That Smell? Another Johnson & Johnson Recall

Pharmalot

Wed, 05/11/11 - 10:35 am

J&J, U.S. Sue Teva to Block Generic Version of Prezista HIV Drug

Bloomberg

Sat, 03/19/11 - 10:50 am

Teva Pharmaceuticals

J&J, U.S. Sue Teva to Block Generic Version of Prezista HIV Drug

Bloomberg

Fri, 03/18/11 - 07:59 pm

Teva Pharmaceuticals

J&J, U.S. Sue Mylan and Lupin to Block Generic Copy of HIV Drug

Bloomberg

Thu, 11/18/10 - 06:39 pm